Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches
BD Shah, P Martin, EM Sotomayor - Cancer Control, 2012 - journals.sagepub.com
Background Mantle cell lymphoma (MCL) remains incurable using conventional
chemotherapeutic approaches. New clinical data show that some patients have a …
chemotherapeutic approaches. New clinical data show that some patients have a …
Migration and adhesion of B-lymphocytes to specific microenvironments in mantle cell lymphoma: interplay between signaling pathways and the epigenetic landscape
L Sadeghi, AP Wright - International Journal of Molecular Sciences, 2021 - mdpi.com
Lymphocyte migration to and sequestration in specific microenvironments plays a crucial
role in their differentiation and survival. Lymphocyte trafficking and homing are tightly …
role in their differentiation and survival. Lymphocyte trafficking and homing are tightly …
Genetic and environmental determinants in multiple myeloma: Implications for therapy
KH Shain, WS Dalton - … Cancers: From Molecular Pathobiology to Targeted …, 2012 - Springer
Multiple myeloma is an incurable hematopoietic malignancy linked to more than 10,000
deaths annually. This dyscrasia is associated with significant co-morbidities as a result of the …
deaths annually. This dyscrasia is associated with significant co-morbidities as a result of the …
Les inhibiteurs des histone-désacétylases en onco-hématologie
R Lemal, A Ravinet, C Moluçon-Chabrot, JO Bay… - Bulletin du cancer, 2011 - Elsevier
Résumé Les inhibiteurs d'histone désacétylases (HDACi) correspondent à une nouvelle
classe de molécules faisant actuellement l'objet de nombreuses publications en …
classe de molécules faisant actuellement l'objet de nombreuses publications en …
Molecular Biology of Mantle Cell Lymphoma
B Shah, P Martin, J Tao, EM Sotomayor - Hematologic Cancers: From …, 2012 - Springer
Mantle cell lymphoma (MCL) is an aggressive Non-Hodgkin's lymphoma with nearly uniform
tendency for recurrence and untimely demise despite intensive chemotherapeutic …
tendency for recurrence and untimely demise despite intensive chemotherapeutic …